Nigel J. Murtagh, serving as the Chief Risk Officer for Charles Schwab Corp. (NASDAQ:SCHW), has finalized a series of transactions involving the company's equity, as documented in a Form 4 filing submitted to the Securities and Exchange Commission. The filing details a sale executed on July 21, 2026, wherein Mr. Murtagh liquidated 4,053 shares of common stock. The aggregate value derived from this divestment totaled approximately $422,068.
The execution of these sales occurred within a specific price band, ranging from $104.12 to $104.405 per share. The weighted average price at which these shares were sold was calculated at $104.1374. This transaction was conducted in strict adherence to a Rule 10b5-1 trading plan, a mechanism designed to facilitate pre-arranged stock transactions. Mr. Murtagh originally established this particular trading plan on November 25, 2025, structuring the parameters for future equity activity.
Concurrently with the sale, Mr. Murtagh engaged in the acquisition of additional equity through the exercise of nonqualified stock options. He exercised options to acquire 4,053 shares of Charles Schwab common stock. The acquisition was executed at an exercise price of $46.81 per share, resulting in a total cost of approximately $189,720. These specific options were granted under the provisions of the company’s 2013 Stock Incentive Plan. The vesting schedule for these grants was structured to release in four annual installments following the initial grant date.
Post-transaction, the executive's direct holdings in Charles Schwab common stock stand at 57,972.4846 shares. Indirect holdings are also reported, with an additional 2,621 shares held through an Employee Stock Purchase Plan (ESPP), as detailed in a plan statement dated July 15, 2026. Furthermore, Mr. Murtagh retains a position in unexercised options, holding 48,622 nonqualified stock options that remain outstanding.
This insider activity unfolds as Charles Schwab reports significant financial results for the second quarter of 2026. The firm delivered earnings that exceeded Wall Street consensus. The adjusted earnings per share were reported at $1.62, driven by revenue reaching $7.1 billion. These figures surpassed analyst estimates, which had projected earnings of $1.54 per share and revenue of $6.85 billion. The financial performance marks a substantial year-over-year expansion, with revenue increasing by 21% and earnings rising by 42%.
The strong quarterly performance has influenced analyst sentiment and price target adjustments. UBS upgraded its price target for Charles Schwab to $128, while maintaining a Buy rating. The firm cited the positive quarterly results and higher future guidance as primary drivers for the adjustment. Wolfe Research similarly raised its price target to $127, referencing the positive quarterly results and elevated guidance. Citizens maintained its Market Outperform rating, noting the earnings beat as a key factor. Piper Sandler adjusted its price target to $118, pointing to a constructive retail trading environment and observed balance sheet growth. These developments underscore the firm's strong performance and continued client growth.
Market valuation metrics for Charles Schwab present a P/E ratio of 18.43 and a PEG ratio of 0.38. These figures suggest an attractive valuation relative to the company's growth prospects. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value assessment. The stock is currently trading at 101.59, reflecting a change of +0.79 or +0.78% as of the last close. After-hours trading indicates a price of 101.37, down -0.24 or -0.24%.